Stocks Trend Analysis: Nuance Communications, Inc. (NUAN), The Blackstone Group L.P. (BX), Commercial Metals Company (CMC)

Nuance Communications, Inc. (NUAN) managed to rebound with the stock declining -0.83% or $-0.13 to close the day at $15.44 on light trading volume of 2.73M shares, compared to its three month average trading volume of 2.83M. The Burlington Massachusetts 01803 based company has been underperforming the application software group over the past 52 weeks, with the stock losing -14.98%, compared to the industry which has advanced 16.75% over the same period. With RSI of 51.41, the stock should still continue to rise and get closer to its one year target estimate of $20.67, making it a hold for now.

Nuance Communications, Inc. provides voice recognition and natural language understanding solutions worldwide. It operates through four segments: Healthcare, Mobile, Enterprise, and Imaging. The Healthcare segment offers transcription solutions, which enables physicians to streamline clinical documentation with medical transcription platform; Dragon Medical, a dictation software that empowers physicians to accurately capture and document patient care in real-time on various devices; clinical document improvement and coding solutions to ensure patient health information is accurately documented, coded, and evaluated; and diagnostic solutions that allows radiologists to document, collaborate, and share medical images and reports. It also provides Dragon professional and personal productivity solutions to business users and consumers. The Mobile segment provides a portfolio of virtual assistants and connected services built on voice recognition, text-to-speech, natural language understanding, dialog, and text input technologies to automotive manufacturers, device makers, and mobile operators. The Enterprise segment offers OnPremise solutions and services, an automated customer service solution comprising speech recognition, voice biometrics, transcription, text-to-speech, and dialog and analytics products; and OnDemand multichannel cloud, a platform that offers enterprises the ability to implement automatic customer service. The Imaging segment provides MFP Scan automation solutions to offer scanning and document management solutions; MFP Print automation solutions to deliver printing and document management solutions; and PDF and OCR software, a technology that enables the capture, creation, and management of document workflows. The company was formerly known as ScanSoft, Inc. and changed its name to Nuance Communications, Inc. in October 2005. Nuance Communications, Inc. was founded in 1992 and is headquartered in Burlington, Massachusetts.

The Blackstone Group L.P. (BX) retreated with the stock falling -0.3% or $-0.09 to close at $29.58 on light trading volume of 2.72M compared its three months average trading volume of 5.05M. The New York New York 10154 based company operating under the Asset Management industry has been trending up for the last 52 weeks, with the shares price now 31.24% up for the period and up by 9.43% so far this year. With price target of $33.85 and a 41.24% rebound from 52-week low, The Blackstone Group L.P. has plenty of upside potential, making it a hold with a view buy.

The Blackstone Group L.P. is a publicly owned hedge fund sponsor. The firm also provides financial advisory services to its clients. It provides its services to public and corporate pension funds, academic, cultural, and charitable organizations, retirees, sovereign wealth funds, and institutional and individual investors. The firm manages separate client focused portfolios for its clients. It launches fixed income mutual funds. The firm also launches and manages private equity funds, real estate funds, funds of hedge funds, and credit-focused funds for its clients. It invests in private equity, public equity, fixed income, and alternative investment markets. The Blackstone Group L.P. was founded in 1985 and is based in New York, New York with additional offices in London, United Kingdom, Hong Kong, Beijing, China, Dubai, UAE, Dusseldorf, Germany, Los Angeles, Santa Monica, Mexico City, Mexico, Paris, France, Sao Paulo, Brazil, Seoul, Korea, Shanghai, China, Singapore, Sydney, Australia, Copenhagen, Denmark, and Tokyo, Japan.

Commercial Metals Company (CMC) managed to rebound with the stock climbing 3.93% or $0.79 to close the day at $20.87 on higher than average trading volume of 2.71M shares, compared to its three month average trading volume of 1.91M. The Irving Texas 75039 based company has been outperforming the steel & iron companies by 35.134% for last three months and its recent gains have offset losses to -3.63% YTD, versus the steel & iron industry which is up 7.23% for the same period. The RSI of 43.56 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Commercial Metals Company manufactures, recycles, and markets steel and metal products, and related materials and services in the United States and internationally. It operates through five segments: Americas Recycling, Americas Mills, Americas Fabrication, International Mill, and International Marketing and Distribution. The Americas Recycling segment processes and sells scrap metals to steel mills and foundries, aluminum sheet and ingot manufacturers, brass and bronze ingot makers, copper refineries and mills, secondary lead smelters, specialty steel mills, high temperature alloy manufacturers, and other consumers. The Americas Mills segment manufactures finished long steel products, including reinforcing bars, merchant bars, light structural products, and other special sections, as well as semi-finished billets for re-rolling and forging applications. This segment sells its products to construction, service center, transportation, steel warehousing, fabrication, energy, petrochemical, and original equipment manufacturing industries. The Americas Fabrication segment offers fabricated steel products for use in the construction of commercial and non-commercial buildings, hospitals, convention centers, industrial plants, power plants, highways, bridges, arenas, stadiums, and dams. The International Mill segment manufactures rebars, merchant bars, and wire rods, as well as semi-finished billets; and sells fabricated rebars, fabricated meshes, assembled rebar cages, and other rebar by-products. This segment sells its products to fabricators, manufacturers, distributors, and construction companies. The International Marketing and Distribution segment processes, sells, and distributes steel products, ferrous and nonferrous metals, and other industrial products to manufacturers in the steel, nonferrous metals, metal fabrication, chemical, refractory, construction, and transportation industries. The company was founded in 1915 and is headquartered in Irving, Texas.

 

Stocks To Watch: The Blackstone Group L.P. (BX), Coeur Mining, Inc. (CDE), EOG Resources, Inc. (EOG)

The Blackstone Group L.P. (BX) traded within a range of $29.39 to $30.2 after opening the day at $30.17. The company has seen its stock increase in value by 9.77% so far this year. The stock was down close to -1.4% on light volume in last trading session and closed at $29.67 per share. After the recent fall, the stock is currently holding -4.78% below its 52 week high of $31.16 and 41.67% above its 12-month low of $22.31. The shares are up by over 27.44% in the last three months, and the RSI indicator value of 58.3 is neither bullish nor bearish, tempting investors to stay on the sidelines.

The Blackstone Group L.P. is a publicly owned hedge fund sponsor. The firm also provides financial advisory services to its clients. It provides its services to public and corporate pension funds, academic, cultural, and charitable organizations, retirees, sovereign wealth funds, and institutional and individual investors. The firm manages separate client focused portfolios for its clients. It launches fixed income mutual funds. The firm also launches and manages private equity funds, real estate funds, funds of hedge funds, and credit-focused funds for its clients. It invests in private equity, public equity, fixed income, and alternative investment markets. The Blackstone Group L.P. was founded in 1985 and is based in New York, New York with additional offices in London, United Kingdom, Hong Kong, Beijing, China, Dubai, UAE, Dusseldorf, Germany, Los Angeles, Santa Monica, Mexico City, Mexico, Paris, France, Sao Paulo, Brazil, Seoul, Korea, Shanghai, China, Singapore, Sydney, Australia, Copenhagen, Denmark, and Tokyo, Japan.

Coeur Mining, Inc. (CDE) continued its upward trend with the stock climbing 1.84% or $0.21 to close the day at $11.6 on light trading volume of 3.9M shares, compared to its three month average trading volume of 4.47M. The Chicago Illinois 60603 based company has been outperforming the silver group over the past 52 weeks, with the stock gaining 510.53%, compared to the industry which has advanced 2.42% over the same period. With RSI of 66.06, the stock should still continue to rise and get closer to its one year target estimate of $13.06, making it a hold for now.

Coeur Mining, Inc. owns, operates, explores for, and develops silver and gold properties. The company holds interests in the Palmarejo silver-gold mine located in Mexico; Rochester silver and gold mine in northwestern Nevada; Kensington gold mine located to the north of Juneau, Alaska; and Wharf gold mine in South Dakota. It also owns the San Bartolomé silver mine in Bolivia; Endeavor zinc, lead, and silver mine located in Australia; La Preciosa silver-gold exploration project in the State of Durango, Mexico; and Joaquin silver-gold exploration project located in the Santa Cruz province of southern Argentina. In addition, the company holds royalty interests in the Cerro Bayo mine in Chile; El Gallo complex in Mexico; Zaruma mine in Ecuador; and Correnso gold mine in New Zealand, as well as other precious metal properties. Coeur Mining, Inc. markets its silver and gold concentrates to third-party refiners and smelters in the United States, China, and Japan. The company was formerly known as Coeur d’Alene Mines Corporation and changed its name to Coeur Mining, Inc. in May 2013. Coeur Mining, Inc. was founded in 1928 and is based in Chicago, Illinois.

EOG Resources, Inc. (EOG) gained $0.09 to close the day at a new closing price of $105.48, a 0.09% increase in value from its previous closing price that moved the stock 85.96% above its 52 week low of $57.15. A total of 3.88M shares exchanged hands during the day compared with its three month average trading volume of 3.6M. The stock, which fluctuated between $105.45 and $106.76 during the day, currently situated -3.4% below its 52 week high. The stock is up by 1.38% in the past one month and up by 11.82% over the past three months. With a one year target estimate of $111.21 and RSI of 61.23, the stock still has upside potential, making it a hold for now.

EOG Resources, Inc., together with its subsidiaries, explores for, develops, produces, and markets crude oil and natural gas. The company’s principal producing areas are located in New Mexico, North Dakota, Texas, Utah, and Wyoming in the United States; and Canada, the Republic of Trinidad and Tobago, the United Kingdom, and the People’s Republic of China. As of December 31, 2015, it had total estimated net proved reserves of 2,118 million barrels of oil equivalent, including 1,098 million barrels (MMBbl) crude oil and condensate reserves; 383 MMBbl of natural gas liquid reserves; and 3,825 billion cubic feet of natural gas reserves. EOG Resources, Inc. was founded in 1985 and is headquartered in Houston, Texas.

 

Stocks Roundup: Community Health Systems, Inc. (CYH), The Blackstone Group L.P. (BX), Parsley Energy, Inc. (PE)

Community Health Systems, Inc. (CYH) grew with the stock adding 5.32% or $0.35 to close at $6.93 on light trading volume of 3.54M compared its three months average trading volume of 5.53M. The Franklin Tennessee 37067 based company operating under the Hospitals industry has been trending down for the last 52 weeks, with the shares price now -59.31% down for the period and up by 23.97% so far this year. With price target of $6.78 and a 66.99% rebound from 52-week low, Community Health Systems, Inc. has plenty of upside potential, making it a hold with a view buy.

Community Health Systems, Inc., together with its subsidiaries, owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at urgent care centers, occupational medicine clinics, imaging centers, cancer centers, ambulatory surgery centers, and home health and hospice agencies. In addition, it offers management and consulting services to non-affiliated general acute care hospitals. As of February 15, 2016, the company owned, leased, or operated 195 affiliated hospitals in 29 states with approximately 30,000 licensed beds. Community Health Systems, Inc. was founded in 1985 and is headquartered in Franklin, Tennessee.

The Blackstone Group L.P. (BX) had a light trading with around 3.49M shares changing hands compared to its three month average trading volume of 5.06M. The stock traded between $30.09 and $30.48 before closing at the price of $30.09 with -0.36% change on the day. The New York New York 10154 based company is currently trading 43.67% above its 52 week low of $22.31 and -3.43% below its 52 week high of $31.16. Both the RSI indicator and target price of  and $33.85 respectively, lead us to believe that it could rise over the coming weeks.

The Blackstone Group L.P. is a publicly owned hedge fund sponsor. The firm also provides financial advisory services to its clients. It provides its services to public and corporate pension funds, academic, cultural, and charitable organizations, retirees, sovereign wealth funds, and institutional and individual investors. The firm manages separate client focused portfolios for its clients. It launches fixed income mutual funds. The firm also launches and manages private equity funds, real estate funds, funds of hedge funds, and credit-focused funds for its clients. It invests in private equity, public equity, fixed income, and alternative investment markets. The Blackstone Group L.P. was founded in 1985 and is based in New York, New York with additional offices in London, United Kingdom, Hong Kong, Beijing, China, Dubai, UAE, Dusseldorf, Germany, Los Angeles, Santa Monica, Mexico City, Mexico, Paris, France, Sao Paulo, Brazil, Seoul, Korea, Shanghai, China, Singapore, Sydney, Australia, Copenhagen, Denmark, and Tokyo, Japan.

Parsley Energy, Inc. (PE) saw its value increase by 0.22% as the stock gained $0.08 to finish the day at a closing price of $36.56. The stock was higher in trading and has fluctuated between $14.51-$39.82 per share for the past year. The shares, which traded within a range of $35.81 to $36.88 during the day, are up by 0.83% in the past three months and up by 28.82% over the past six months. It is currently trading 1.84% above its 20 day moving average and 2.95% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $44.73 a share over the next twelve months. The current relative strength index (RSI) reading is 56.08.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Parsley Energy, Inc., an independent oil and natural gas company, engages in the acquisition, development, production, exploration, and sale of crude oil and natural gas properties in the Permian Basin located in West Texas and Southeastern New Mexico. As of December 31, 2015, its acreage position consisted of 110,967 net acres, including 84,441 net acres in the Midland Basin and 26,526 net acres in the Delaware Basin; and estimated proved oil and natural gas reserves were 123.8 MMBoe. The company was founded in 2008 and is headquartered in Austin, Texas.

 

Stocks in Focus: American Eagle Outfitters, Inc. (AEO), The Blackstone Group L.P. (BX), PDL BioPharma, Inc. (PDLI)

American Eagle Outfitters, Inc. (AEO) had a light trading with around 3.8M shares changing hands compared to its three month average trading volume of 5.78M. The stock traded between $14.93 and $15.45 before closing at the price of $15.11 with -0.85% change on the day. The Pittsburgh Pennsylvania 15203 based company is currently trading 21.88% above its 52 week low of $12.78 and -21.57% below its 52 week high of $19.55. Both the RSI indicator and target price of 40.92 and $18.55 respectively, lead us to believe that it should be put on hold over the coming weeks.

American Eagle Outfitters, Inc. operates as a specialty retailer offering on-trend clothing, accessories, and personal care products under the American Eagle Outfitters and Aerie brands. The company provides denim, bottoms, and other apparel, as well as footwear and accessories for men and women; and intimates, including bras, undies, swim, and other products, as well as apparel and personal care products for women. In addition, it offers sports apparel under the Tailgate brand; and menswear products under the Todd Snyder New York brand name. The company operates approximately 1,000 stores in the United States, Canada, Mexico, China, Hong Kong, and the United Kingdom, and ships to 81 countries through its websites. It also offers its merchandise at 151 stores operated by licensees in 22 countries, as well as through its Websites at ae.com, aerie.com, TailgateClothing.com, and ToddSnyder.com. American Eagle Outfitters, Inc. was founded in 1977 and is headquartered in Pittsburgh, Pennsylvania.

The Blackstone Group L.P. (BX) managed to rebound with the stock climbing 0.47% or $0.14 to close the day at $30.21 on light trading volume of 3.8M shares, compared to its three month average trading volume of 5.07M. The New York New York 10154 based company has been outperforming the asset management group over the past 52 weeks, with the stock gaining 27.86%, compared to the industry which has advanced 25.26% over the same period. With RSI of 66.11, the stock should still continue to rise and get closer to its one year target estimate of $32.92, making it a hold for now.

The Blackstone Group L.P. is a publicly owned hedge fund sponsor. The firm also provides financial advisory services to its clients. It provides its services to public and corporate pension funds, academic, cultural, and charitable organizations, retirees, sovereign wealth funds, and institutional and individual investors. The firm manages separate client focused portfolios for its clients. It launches fixed income mutual funds. The firm also launches and manages private equity funds, real estate funds, funds of hedge funds, and credit-focused funds for its clients. It invests in private equity, public equity, fixed income, and alternative investment markets. The Blackstone Group L.P. was founded in 1985 and is based in New York, New York with additional offices in London, United Kingdom, Hong Kong, Beijing, China, Dubai, UAE, Dusseldorf, Germany, Los Angeles, Santa Monica, Mexico City, Mexico, Paris, France, Sao Paulo, Brazil, Seoul, Korea, Shanghai, China, Singapore, Sydney, Australia, Copenhagen, Denmark, and Tokyo, Japan.

PDL BioPharma, Inc. (PDLI) shares were down in last trading by -0.85% to $2.32. It experienced higher than average volume on day. The stock increased in value by almost 0.87% over the past week and grew 3.57% in the past month. It is currently trading -9.42% below its 50 day moving average and -24.37% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -38.7% decrease in value from its one year high of $3.84. The RSI indicator value of 48.5, lead us to believe that it is a hold for now.

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets in the United States and Europe. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. PDL BioPharma, Inc. has license agreements with various biotechnology and pharmaceutical companies, as well as acquires royalty and other assets. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.

 

Stocks Trend Analysis: The Blackstone Group L.P. (BX) AMAG Pharmaceuticals, Inc. (AMAG) Fifth Third Bancorp (FITB)

The Blackstone Group L.P. (BX) continued its downward trend with the stock declining -1.31% or $-0.4 to close the day at $30.07 on active trading volume of 5.26M shares, compared to its three month average trading volume of 5.02M. The New York New York 10154 based company has been outperforming the asset management group over the past 52 weeks, with the stock gaining 29.95%, compared to the industry which has advanced 25.59% over the same period. With RSI of 65.97, the stock should still continue to rise and get closer to its one year target estimate of $32.92, making it a hold for now.

The Blackstone Group L.P. is a publicly owned hedge fund sponsor. The firm also provides financial advisory services to its clients. It provides its services to public and corporate pension funds, academic, cultural, and charitable organizations, retirees, sovereign wealth funds, and institutional and individual investors. The firm manages separate client focused portfolios for its clients. It launches fixed income mutual funds. The firm also launches and manages private equity funds, real estate funds, funds of hedge funds, and credit-focused funds for its clients. It invests in private equity, public equity, fixed income, and alternative investment markets. The Blackstone Group L.P. was founded in 1985 and is based in New York, New York with additional offices in London, United Kingdom, Hong Kong, Beijing, China, Dubai, UAE, Dusseldorf, Germany, Los Angeles, Santa Monica, Mexico City, Mexico, Paris, France, Sao Paulo, Brazil, Seoul, Korea, Shanghai, China, Singapore, Sydney, Australia, Copenhagen, Denmark, and Tokyo, Japan.

AMAG Pharmaceuticals, Inc. (AMAG) grew with the stock adding 0.43% or $0.1 to close at $23.1 on active trading volume of 5.26M compared its three months average trading volume of 1.09M. The Waltham Massachusetts 02451 based company operating under the Diagnostic Substances industry has been trending down for the last 52 weeks, with the shares price now -1.07% down for the period and down by -33.62% so far this year. With price target of $37.4 and a 28.91% rebound from 52-week low, AMAG Pharmaceuticals, Inc. has plenty of upside potential, making it a hold with a view buy.

AMAG Pharmaceuticals, Inc., a specialty pharmaceutical company, provides products and services with a focus on maternal health, anemia management, and cancer supportive care in the United States. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Feraheme (ferumoxytol) injection for use as an intravenous (IV) iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. The company also offers Cord Blood Registry services that are related to the collection, processing, and storage of umbilical cord blood and cord tissue units. In addition, it has a license agreement with Velo to acquire the rights to digoxin immune fab, a polyclonal antibody in clinical development for the treatment of severe preeclampsia in pregnant women. The company sells Feraheme to authorized wholesalers and specialty distributors. AMAG Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.

Fifth Third Bancorp (FITB) managed to rebound with the stock climbing 1.16% or $0.31 to close the day at $27.07 on lower than average trading volume of 5.24M shares, compared to its three month average trading volume of 7.76M. The Cincinnati Ohio 45263 based company has been outperforming the regional – midwest banks companies by 31.3246% for last three months and its recent gains have pushed the stock slightly up 0.37% YTD, versus the regional – midwest banks industry which is down -0.22% for the same period. The RSI of 57.56 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Fifth Third Bancorp operates as a diversified financial services company in the United States. It operates through four segments: Commercial Banking, Branch Banking, Consumer Lending, and Investment Advisors. The Commercial Banking segment offers credit intermediation, cash management, and financial services; lending and depository products; and foreign exchange and international trade finance, derivatives and capital markets services, asset-based lending, real estate finance, public finance, commercial leasing, and syndicated finance for business, government, and professional customers. The Branch Banking segment provides deposit and loan products to individuals and small businesses. This segment offers checking and savings accounts, home equity loans and lines of credit, credit cards, and loans for automobiles and personal financing needs. The Consumer Lending segment engages in direct lending activities that include origination, retention, and servicing of residential mortgage and home equity loans or lines of credit; and indirect lending activities, including loans to consumers through correspondent lenders and automobile dealers. The Investment Advisors segment provides various investment alternatives for individuals, companies, and not-for-profit organizations. It offers retail brokerage services to individual clients; and broker dealer services to the institutional marketplace. This segment also provides asset management services; holistic strategies to affluent clients in wealth planning, investing, insurance, and wealth protection; and advisory services for institutional clients comprising states and municipalities. As of December 31, 2015, the company operated 1,254 full-service banking centers, including 95 Bank Mart locations, as well as 2,593 automated teller machines in 12 states throughout the Midwestern and Southeastern regions of the United States. Fifth Third Bancorp was founded in 1862 and is headquartered in Cincinnati, Ohio.

 

3 Trending Stocks: Devon Energy Corporation (DVN), The Blackstone Group L.P. (BX), Boston Scientific Corporation (BSX)

Devon Energy Corporation (DVN) continued its downward trend with the stock declining -4.29% or $-2.09 to close the day at $46.58 on active trading volume of 5.74M shares, compared to its three month average trading volume of 5.17M. The Oklahoma City Oklahoma 73102 based company has been outperforming the independent oil & gas group over the past 52 weeks, with the stock gaining 65.92%, compared to the industry which has advanced 43.86% over the same period. With RSI of 50.39, the stock should still continue to rise and get closer to its one year target estimate of $51.3, making it a hold for now.

Devon Energy Corporation, an independent energy company, primarily engages in the exploration, development, and production of oil, natural gas, and natural gas liquids (NGLs) in the United States and Canada. It operates approximately 19,000 wells. The company also offers midstream energy services, including gathering, transmission, processing, fractionation, and marketing to producers of natural gas, NGLs, crude oil, and condensate through its natural gas pipelines, plants, and treatment facilities. Devon Energy Corporation was founded in 1971 and is headquartered in Oklahoma City, Oklahoma.

The Blackstone Group L.P. (BX) fell -0.13% during last trading as the stock lost $-0.04 to finish the day at $30.47 with about 5.65M shares changing hands, compared to its three month average trading volume of 4.97M. The $36.34B market cap company, which fluctuated between $30.17 and $31.16 during the day, currently situated 45.49% above its 52 week low of $22.31 and -1.42% away from its one year high of $31.16. The RSI of 69.93 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

The Blackstone Group L.P. is a publicly owned hedge fund sponsor. The firm also provides financial advisory services to its clients. It provides its services to public and corporate pension funds, academic, cultural, and charitable organizations, retirees, sovereign wealth funds, and institutional and individual investors. The firm manages separate client focused portfolios for its clients. It launches fixed income mutual funds. The firm also launches and manages private equity funds, real estate funds, funds of hedge funds, and credit-focused funds for its clients. It invests in private equity, public equity, fixed income, and alternative investment markets. The Blackstone Group L.P. was founded in 1985 and is based in New York, New York with additional offices in London, United Kingdom, Hong Kong, Beijing, China, Dubai, UAE, Dusseldorf, Germany, Los Angeles, Santa Monica, Mexico City, Mexico, Paris, France, Sao Paulo, Brazil, Seoul, Korea, Shanghai, China, Singapore, Sydney, Australia, Copenhagen, Denmark, and Tokyo, Japan.

Boston Scientific Corporation (BSX) saw its value increase by 0.18% as the stock gained $0.04 to finish the day at a closing price of $22.19. The stock was lighter in trading and has fluctuated between $15.67-$24.79 per share for the past year. The shares, which traded within a range of $22.11 to $22.27 during the day, are down by -5.49% in the past three months and down by -6.65% over the past six months. It is currently trading 3.08% above its 20 day moving average and 3.75% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $27.55 a share over the next twelve months. The current relative strength index (RSI) reading is 62.99. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; coronary technology products to treat atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.

 

Stocks Highlights: Exelon Corporation (EXC), Novavax, Inc. (NVAX), The Blackstone Group L.P. (BX)

Exelon Corporation (EXC) had a active trading with around 6.32M shares changing hands compared to its three month average trading volume of 6.19M. The stock traded between $35.32 and $36.21 before closing at the price of $36.08 with 1.63% change on the day. The Chicago Illinois 60680 based company is currently trading 42.69% above its 52 week low of $26.26 and -2.47% below its 52 week high of $37.7. Both the RSI indicator and target price of 62.54 and $37.69 respectively, lead us to believe that it should be put on hold over the coming weeks.

Exelon Corporation, a utility services holding company, engages in the energy generation and delivery businesses in the United States and Canada. It owns electric generating facilities, such as nuclear, fossil, and hydroelectric generation facilities, as well as wind and solar facilities. The company also sells renewable energy and other energy-related products and services; and engages in natural gas and oil exploration and production activities, as well as sells electricity and natural gas to wholesale and retail customers. In addition, it is involved in the purchase and regulated retail sale of electricity, and the provision of electricity transmission and distribution services to retail customers in northern Illinois, southeastern Pennsylvania, and central Maryland. Further, the company engages in the purchase and regulated retail sale of natural gas, and the provision of gas distribution services to retail customers in the Pennsylvania counties surrounding the City of Philadelphia, as well as in central Maryland, including the City of Baltimore. It serves distribution utilities, municipalities, cooperatives, and financial institutions, as well as commercial, industrial, governmental, and residential customers. The company was founded in 1887 and is headquartered in Chicago, Illinois.

Novavax, Inc. (NVAX) continued its upward trend with the stock climbing 3.79% or $0.05 to close the day at $1.37 on light trading volume of 6.17M shares, compared to its three month average trading volume of 8.52M. The Gaithersburg Maryland 20878 based company has been underperforming the biotechnology group over the past 52 weeks, with the stock losing -80.2%, compared to the industry which has dropped -1.38% over the same period. With RSI of 51.75, the stock should still continue to rise and get closer to its one year target estimate of $3.29, making it a hold for now.

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization that are in Phase III clinical trials, as well as pediatric RSV candidate, which is in Phase I clinical trial; seasonal quadrivalent influenza and pandemic H7N9 vaccines, which are in Phase II clinical trials; vaccine candidate against Ebola Virus that is Phase I clinical trial, as well as combination respiratory vaccine candidate and seasonal influenza vaccine candidate that is in pre-clinical trial; and rabies G protein vaccine candidate, which is in Phase I/II clinical trial. The company also has pre-clinical stage programs for various infectious diseases, including the Middle East respiratory syndrome coronavirus; and develops technology for the production of immune stimulating saponin-based adjuvants. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.

The Blackstone Group L.P. (BX) shares were up in last trading by 0.3% to $30.51. It experienced higher than average volume on day. The stock increased in value by almost 12.38% over the past week and grew 14.92% in the past month. It is currently trading 14.57% above its 50 day moving average and 17.98% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -0.39% decrease in value from its one year high of $30.91. The RSI indicator value of 70.55, lead us to believe that it may reverse gains in the near term.

The Blackstone Group L.P. is a publicly owned hedge fund sponsor. The firm also provides financial advisory services to its clients. It provides its services to public and corporate pension funds, academic, cultural, and charitable organizations, retirees, sovereign wealth funds, and institutional and individual investors. The firm manages separate client focused portfolios for its clients. It launches fixed income mutual funds. The firm also launches and manages private equity funds, real estate funds, funds of hedge funds, and credit-focused funds for its clients. It invests in private equity, public equity, fixed income, and alternative investment markets. The Blackstone Group L.P. was founded in 1985 and is based in New York, New York with additional offices in London, United Kingdom, Hong Kong, Beijing, China, Dubai, UAE, Dusseldorf, Germany, Los Angeles, Santa Monica, Mexico City, Mexico, Paris, France, Sao Paulo, Brazil, Seoul, Korea, Shanghai, China, Singapore, Sydney, Australia, Copenhagen, Denmark, and Tokyo, Japan.

 

Traders Recap: Merrimack Pharmaceuticals, Inc. (MACK), Bonanza Creek Energy Inc. (BCEI), The Blackstone Group L.P. (BX)

Merrimack Pharmaceuticals, Inc. (MACK) failed to extend gains with the stock declining -7.09% or $-0.29 to close the day at $3.8 on higher than average trading volume of 7.73M shares, compared to its three month average trading volume of 3.09M. The Cambridge Massachusetts 02139 based company has been outperforming the biotechnology companies by -36.2768% for last three months and its recent losses have pulled the stock down -6.86% YTD, versus the biotechnology industry which is up 2.45% for the same period. The RSI of 30.87 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer primarily in the United States. The company offers ONIVYDE that is used for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. Its therapeutic oncology candidates in clinical development include MM-398, which is in Phase II clinical trials for the treatment of patients with previously untreated, metastatic pancreatic adenocarcinoma; Phase I clinical trials for the treatment of patients with glioma, pediatric solid tumors, and gastrointestinal tumors; and Phase I clinical trials for treating metastatic breast cancer. The company’s therapeutic oncology candidates also include MM-302 that is in Phase II clinical trials for the treatment of patients with ErbB2 (HER2) positive, locally advanced or metastatic breast cancer; and MM-121, which is in Phase II clinical trial for the treatment of patients with heregulin positive, advanced non-small cell lung cancer. In addition, its therapeutic oncology candidates consist of MM-141 that is in Phase II clinical trials for the treatment of previously untreated metastatic pancreatic cancer patients who have high serum levels of free IGF-1; and MM-151 and MM-141, which are in Phase I clinical trials for the treatment of patients with solid tumors. The company has license and collaboration agreements with Baxter International Inc., Baxter Healthcare Corporation, and Baxter Healthcare SA; development, license, and supply agreement with Watson Laboratories, Inc.; sublicense and collaboration agreement with PharmaEngine, Inc.; collaboration agreements with Dyax Corp. and Adimab LLC,; and license agreement with University of California. Merrimack Pharmaceuticals, Inc. was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Bonanza Creek Energy Inc. (BCEI) had a active trading with around 7.66M shares changing hands compared to its three month average trading volume of 3.24M. The stock traded between $1.25 and $1.63 before closing at the price of $1.55 with 12.32% change on the day. The Denver Colorado 80202 based company is currently trading 158.33% above its 52 week low of $0.6 and -70.97% below its 52 week high of $4.7. Both the RSI indicator and target price of 55.88 and $1.03 respectively, lead us to believe that it should be put on hold over the coming weeks.

Bonanza Creek Energy Inc., an independent energy company, engages in the acquisition, exploration, development, and production of onshore oil and associated liquids-rich natural gas in the United States. The company’s oil and liquids weighted assets are located primarily in the Wattenberg Field in Colorado; and the Dorcheat Macedonia Field in southern Arkansas. It also owns and operates oil-producing assets in the North Park Basin in Colorado; and the McKamie Patton Field in Southern Arkansas. Bonanza Creek Energy Inc. was founded in 2010 and is headquartered in Denver, Colorado.

The Blackstone Group L.P. (BX) traded within a range of $29.7 to $30.63 after opening the day at $29.85. The company has seen its stock increase in value by 12.54% so far this year. The stock was up close to 2.08% on active volume in last trading session and closed at $30.42 per share. After the recent gain, the stock is currently holding -0.2% below its 52 week high of $30.63 and 45.25% above its 12-month low of $22.31. The shares are up by over 23.07% in the last three months, and the RSI indicator value of 70.32 is bearish. The technical indicator is offering a warning sign that the stock can’t keep current pace going.

The Blackstone Group L.P. is a publicly owned hedge fund sponsor. The firm also provides financial advisory services to its clients. It provides its services to public and corporate pension funds, academic, cultural, and charitable organizations, retirees, sovereign wealth funds, and institutional and individual investors. The firm manages separate client focused portfolios for its clients. It launches fixed income mutual funds. The firm also launches and manages private equity funds, real estate funds, funds of hedge funds, and credit-focused funds for its clients. It invests in private equity, public equity, fixed income, and alternative investment markets. The Blackstone Group L.P. was founded in 1985 and is based in New York, New York with additional offices in London, United Kingdom, Hong Kong, Beijing, China, Dubai, UAE, Dusseldorf, Germany, Los Angeles, Santa Monica, Mexico City, Mexico, Paris, France, Sao Paulo, Brazil, Seoul, Korea, Shanghai, China, Singapore, Sydney, Australia, Copenhagen, Denmark, and Tokyo, Japan.

 

Trader Alert: St. Jude Medical, Inc. (STJ), The Blackstone Group L.P. (BX), NIKE, Inc. (NKE)

St. Jude Medical, Inc. (STJ) grew with the stock adding 0.16% or $0.13 to close at $80.82 on light trading volume of 14.74M compared its three months average trading volume of 2.42M. The St. Paul Minnesota 55117 based company operating under the Medical Appliances & Equipment industry has been trending up for the last 52 weeks, with the shares price now 34.78% up for the period and up by 0.79% so far this year. With price target of $81.96 and a 67.79% rebound from 52-week low, St. Jude Medical, Inc. has plenty of upside potential, making it a hold with a view buy.

St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. It operates in two divisions, Implantable Electronic Systems, and Cardiovascular and Ablation Technologies. The company offers tachycardia implantable cardioverter defibrillator systems and cardiac resynchronization therapy defibrillator devices to treat patients with tachycardia. It also provides atrial fibrillation products comprising electrophysiology, introducers and catheters, advanced cardiac mapping, navigation and recording systems, and ablation systems; and pacemakers, which deliver low-voltage electrical impulses to stimulate a heartbeat for patients whose hearts beat too slowly. In addition, the company offers vascular closure devices, compression assist devices, pressure measurement guidewires, diagnostic coronary imaging technology, percutaneous catheter introducers, diagnostic guidewires, heart failure monitoring devices, renal denervation technology and vascular plugs, optical coherence tomography imaging products, and other vascular accessories, as well as CardioMEMS, a heart failure monitoring device. Further, it provides structural heart products, including heart valve replacement and repair products, and structural heart defect devices; neuromodulation products, such as spinal cord stimulation and radiofrequency ablation to treat chronic pain, as well as deep brain stimulation to treat movement disorders; and thoratec products comprising ventricular assist devices and percutaneous heart pumps. The company sells its products through direct sales force and independent distributors. St. Jude Medical, Inc. was founded in 1976 and is headquartered in St. Paul, Minnesota.

The Blackstone Group L.P. (BX) gained $1.68 to close the day at a new closing price of $29.8, a 5.97% increase in value from its previous closing price that moved the stock 42.29% above its 52 week low of $22.31. A total of 14.66M shares exchanged hands during the day compared with its three month average trading volume of 4.7M. The stock, which fluctuated between $28.5 and $30.48 during the day, currently situated -1.49% below its 52 week high. The stock is up by 15.24% in the past one month and up by 20.81% over the past three months. With a one year target estimate of $32.62 and RSI of 67.08, the stock still has upside potential, making it a hold for now.

The Blackstone Group L.P. is a publicly owned hedge fund sponsor. The firm also provides financial advisory services to its clients. It provides its services to public and corporate pension funds, academic, cultural, and charitable organizations, retirees, sovereign wealth funds, and institutional and individual investors. The firm manages separate client focused portfolios for its clients. It launches fixed income mutual funds. The firm also launches and manages private equity funds, real estate funds, funds of hedge funds, and credit-focused funds for its clients. It invests in private equity, public equity, fixed income, and alternative investment markets. The Blackstone Group L.P. was founded in 1985 and is based in New York, New York with additional offices in London, United Kingdom, Hong Kong, Beijing, China, Dubai, UAE, Dusseldorf, Germany, Los Angeles, Santa Monica, Mexico City, Mexico, Paris, France, Sao Paulo, Brazil, Seoul, Korea, Shanghai, China, Singapore, Sydney, Australia, and Tokyo, Japan.

NIKE, Inc. (NKE) shares were up in last trading by 2.1% to $53.07. It experienced higher than average volume on day. The stock increased in value by almost 3.47% over the past week and grew 5.17% in the past month. It is currently trading 3.97% above its 50 day moving average and -3.33% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -18.15% decrease in value from its one year high of $65.44. The RSI indicator value of 62.76, lead us to believe that it is a hold for now.

NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, and accessories worldwide. It offers products in nine categories, including running, NIKE basketball, the Jordan brand, football, men’s training, women’s training, action sports, sportswear, and golf. The company also markets products designed for kids, as well as for other athletic and recreational uses, such as cricket, lacrosse, tennis, volleyball, wrestling, walking, and outdoor activities. In addition, it sells sports apparel; and markets apparel with licensed college and professional team and league logos. Further, the company sells a line of performance equipment, including bags, socks, sport balls, eyewear, timepieces, digital devices, bats, gloves, protective equipment, golf clubs, and other equipment under the NIKE brand name for sports activities; various plastic products to other manufacturers; athletic and casual footwear, apparel, and accessories under the Jumpman trademark; action sports and youth lifestyle apparel and accessories under the Hurley trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks. Additionally, it licenses agreements that permit unaffiliated parties to manufacture and sell apparel, digital devices, and applications and other equipment for sports activities under NIKE-owned trademarks. The company sells its products to footwear stores, sporting goods stores, athletic specialty stores, department stores, skate, tennis and golf shops, and other retail accounts through NIKE-owned retail stores and Internet Websites (direct to consumer operations), as well as independent distributors and licensees. The company was formerly known as Blue Ribbon Sports, Inc. and changed its name to NIKE, Inc. in 1971. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.

 

Traders Recap: The Blackstone Group L.P. (BX), Kimco Realty Corporation (KIM), Avon Products, Inc. (AVP)

The Blackstone Group L.P. (BX) continued its downward trend with the stock declining -0.44% or $-0.12 to close the day at $27.03 on higher than average trading volume of 5.32M shares, compared to its three month average trading volume of 4.62M. The New York New York 10154 based company has been outperforming the asset management companies by 7.5993% for last three months and its recent gains have offset losses to -1.53% YTD, versus the asset management industry which is up 9.01% for the same period. The RSI of 45.13 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

The Blackstone Group L.P. is a publicly owned hedge fund sponsor. The firm also provides financial advisory services to its clients. It provides its services to public and corporate pension funds, academic, cultural, and charitable organizations, retirees, sovereign wealth funds, and institutional and individual investors. The firm manages separate client focused portfolios for its clients. It launches fixed income mutual funds. The firm also launches and manages private equity funds, real estate funds, funds of hedge funds, and credit-focused funds for its clients. It invests in private equity, public equity, fixed income, and alternative investment markets. The Blackstone Group L.P. was founded in 1985 and is based in New York, New York with additional offices in London, United Kingdom, Hong Kong, Beijing, China, Dubai, UAE, Dusseldorf, Germany, Los Angeles, Santa Monica, Mexico City, Mexico, Paris, France, Sao Paulo, Brazil, Seoul, Korea, Shanghai, China, Singapore, Sydney, Australia, and Tokyo, Japan.

Kimco Realty Corporation (KIM) had a active trading with around 5.3M shares changing hands compared to its three month average trading volume of 3.92M. The stock traded between $24.76 and $25.36 before closing at the price of $25.16 with 1.53% change on the day. The New Hyde Park New York 11042 based company is currently trading 4.32% above its 52 week low of $24.35 and -21.27% below its 52 week high of $32.24. Both the RSI indicator and target price of 45.25 and $28.72 respectively, lead us to believe that it should be put on hold over the coming weeks.

Kimco Realty Corporation is an independent real estate investment trust. The firm invests in the real estate markets across North America. It is primarily engaged in acquisitions, development, and management of neighborhood and community shopping centers. The firm also provides property management services relating to the management, leasing, operation, and maintenance of real estate properties. Kimco Realty Corporation was formed in 1966 and is based in New Hyde Park, New York with additional office all across North America.

Avon Products, Inc. (AVP) traded within a range of $4.99 to $5.14 after opening the day at $5.14. The company has seen its stock increase in value by 24.44% so far this year. The stock was down close to -1.95% on light volume in last trading session and closed at $5.04 per share. After the recent fall, the stock is currently holding -27.59% below its 52 week high of $6.96 and 128.05% above its 12-month low of $2.21. The shares are down by over -10.95% in the last three months, and the RSI indicator value of 35.85 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Avon Products, Inc. manufactures and markets beauty and related products worldwide. It offers beauty products, which consists of skincare products, including personal care products, as well as fragrances and color cosmetics; and fashion and home products consisting of jewelry, watches, apparel, footwear, accessories, gift and decorative products, housewares, entertainment and leisure products, children’s products, and nutritional products. The company markets its products through direct selling by representatives. Avon Products, Inc. was founded in 1886 and is headquartered in New York, New York.